TY - JOUR
T1 - Predictive factors of surgical outcomes in vitrectomy for myopic traction maculopathy
AU - HATTORI, KYOKO
AU - KATAOKA, KEIKO
AU - TAKEUCHI, JUN
AU - ITO, YASUKI
AU - TERASAKI, HIROKO
N1 - Funding Information:
K. Kataoka: Alcon Pharma, Japan (Honoraria for lecturing, Grant); Santen Pharmaceutical, Japan (Honoraria for lecturing); and Bayer Health Care, Japan (Honoraria for lecturing). Y. Ito: Alcon Pharma, Japan (Honoraria for lecturing); Bayer Health Care, Japan (Honoraria for lecturing); Canon Life Care Solutions Inc, Japan (Honoraria for lecturing); Carl Zeiss Meditec, Japan (Honorarium for lecturing); Kowa Pharmaceutical Company, Japan (Honoraria for lecturing); Pfizer Japan Inc, Japan (Honoraria for lecturing); and Santen Pharmaceutical, Japan (Honoraria for lecturing). H. Terasaki: Astellas Pharma Inc, Japan (Honorarium for lecturing); Otsuka Pharmaceutical, Japan (Honoraria for lecturing, Grant); ONO PHARMACEUTICAL, Japan (Consulting); SANWA KAGAKU KENKYUSHO, Japan (Honorarium for lecturing); NIDEK, Japan (Honorarium for lecturing); KOWA PHARMACEUTICAL COMPANY, Japan (Honoraria for lecturing, Grant); Santen Pharmaceutical, Japan (Honoraria for lecturing, Grant); Senju Pharmaceutical, Japan (Honoraria for lecturing, Grant); Alcon Pharma, Japan (Honoraria for lecturing, Grant); Bayer Health Care, Japan (Honoraria for lecturing, Consulting, travel expenses); Pfizer Japan Inc, Japan (Honoraria for lecturing, Grant); ROHTO Pharmaceutical, Japan (Rohto Award Selection committee); WAKAMOTO Co, Japan (Honoraria for lecturing, Grant); AICHI OPHTHALMOLOGISTS ASSOCIATION, Japan (Honorarium for lecturing); Carl Zeiss Meditec, Japan (Honorarium for lecturing); Nitten Pharmaceutical, Japan (Writing assistance, Honorarium for lecturing); Takeda Pharmaceutical Company Ltd, Japan (Honorarium for lecturing); Chiba Ophthalmologist Association, Japan (Honorarium for lecturing, travel expense); Japan Medical Association, Japan (Honorarium for lecturing, travel expense); Fukushima Ophthalmologist Association, Japan (Honorarium for lecturing, travel expense); and HOYA CORPORATION, Japan (Grant). The above are financial activities outside the submitted work. The remaining authors have no financial/conflicting interest to disclose.
Funding Information:
Supported in part by Japan Society for the Promotion of Science (JSPS, Tokyo, Japan) KAKENHI Grant (JP16K11265, Y.I.; JP15H40994, H.T.).
Publisher Copyright:
© 2018 Lippincott Williams and Wilkins. All rights reserved.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Purpose: To assess predictive factors and surgical outcomes for myopic traction maculopathy. Methods: This retrospective observational case study enrolled 73 patients who underwent vitrectomy for myopic traction maculopathy. The 79 eyes obtained from our study sample were divided into 4 types: Retinoschisis, lamellar macular hole (lamellar MH), foveal retinal detachment (FRD), and FRD + lamellar MH, or into 2 types according to the presence of FRD preoperatively. Dependent variables of interest were age, sex, pre- and postoperative best-corrected visual acuity (BCVA) at 6 months, and axial length. Results: All the four types showed moderately strong-to-strong positive correlations with pre- and postoperative BCVA (retinochisisi: R = 0.61; lamellar MH: R = 0.62; FRD: R = 0.51; FRD + lamellar MH; r = 0.83). Preoperative BCVA was associated with postoperative BCVA (P , 0.0001), but age, axial length, and the types of preoperative foveal status were not. Eyes with FRD had significantly worse pre- and postoperative BCVA than eyes without FRD (P = 0.036 and P = 0.046, respectively). Postoperative full-thickness macular holes developed in 5.1% of cases and in all types but retinoschisis. Conclusion: Preoperative visual acuity and the presence of FRD should be considered for surgical indication of myopic traction maculopathy.
AB - Purpose: To assess predictive factors and surgical outcomes for myopic traction maculopathy. Methods: This retrospective observational case study enrolled 73 patients who underwent vitrectomy for myopic traction maculopathy. The 79 eyes obtained from our study sample were divided into 4 types: Retinoschisis, lamellar macular hole (lamellar MH), foveal retinal detachment (FRD), and FRD + lamellar MH, or into 2 types according to the presence of FRD preoperatively. Dependent variables of interest were age, sex, pre- and postoperative best-corrected visual acuity (BCVA) at 6 months, and axial length. Results: All the four types showed moderately strong-to-strong positive correlations with pre- and postoperative BCVA (retinochisisi: R = 0.61; lamellar MH: R = 0.62; FRD: R = 0.51; FRD + lamellar MH; r = 0.83). Preoperative BCVA was associated with postoperative BCVA (P , 0.0001), but age, axial length, and the types of preoperative foveal status were not. Eyes with FRD had significantly worse pre- and postoperative BCVA than eyes without FRD (P = 0.036 and P = 0.046, respectively). Postoperative full-thickness macular holes developed in 5.1% of cases and in all types but retinoschisis. Conclusion: Preoperative visual acuity and the presence of FRD should be considered for surgical indication of myopic traction maculopathy.
UR - http://www.scopus.com/inward/record.url?scp=85052833606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052833606&partnerID=8YFLogxK
U2 - 10.1097/IAE.0000000000001927
DO - 10.1097/IAE.0000000000001927
M3 - Article
C2 - 29117066
AN - SCOPUS:85052833606
SN - 0275-004X
VL - 38
SP - S23-S30
JO - Retina
JF - Retina
ER -